X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7) 7
glaucoma (4) 4
burns, chemical - drug therapy (3) 3
ophthalmology (3) 3
pathology (3) 3
tumor necrosis factor-alpha - antagonists & inhibitors (3) 3
abridged index medicus (2) 2
alkali burn (2) 2
animals (2) 2
boston keratoprosthesis (2) 2
brain (2) 2
cells (2) 2
cornea (2) 2
cornea - metabolism (2) 2
corneal injuries - drug therapy (2) 2
disease models, animal (2) 2
expression (2) 2
eye (2) 2
eye burns - drug therapy (2) 2
eye diseases (2) 2
humans (2) 2
immunology (2) 2
in-vitro (2) 2
infliximab - therapeutic use (2) 2
injuries (2) 2
model (2) 2
mouse model (2) 2
neurodegeneration (2) 2
neuroprotective agents - therapeutic use (2) 2
rabbits (2) 2
retina - injuries (2) 2
retina - metabolism (2) 2
retina - pathology (2) 2
retinal protection (2) 2
sense organs (2) 2
tumor necrosis factor alpha (2) 2
tumor necrosis factor-alpha - metabolism (2) 2
activation (1) 1
alkalies (1) 1
alpha-smooth muscle actin (1) 1
anti-inflammatory agents - therapeutic use (1) 1
antibody therapy (1) 1
antirheumatic agents - administration & dosage (1) 1
apoptosis - drug effects (1) 1
apoptosis - physiology (1) 1
artificial corneas (1) 1
association (1) 1
biocompatibility (1) 1
biological sciences (1) 1
blotting, western (1) 1
bone marrow (1) 1
boston type-1 keratoprosthesis (1) 1
brain-injury (1) 1
burn (1) 1
burns, chemical - diagnosis (1) 1
burns, chemical - etiology (1) 1
burns, chemical - metabolism (1) 1
burns, chemical - pathology (1) 1
burns, chemical - surgery (1) 1
carbonic anhydrase inhibitors - therapeutic use (1) 1
care and treatment (1) 1
cell adhesion (1) 1
cell line (1) 1
cell migration (1) 1
cell proliferation (1) 1
central nervous system (1) 1
central-nervous-system (1) 1
chemical burns (1) 1
collagen deposition (1) 1
colony-stimulating factor (1) 1
conjunctiva (1) 1
contribute (1) 1
cornea - cytology (1) 1
cornea - drug effects (1) 1
cornea - immunology (1) 1
cornea - pathology (1) 1
cornea - physiology (1) 1
cornea - surgery (1) 1
corneal injuries - diagnosis (1) 1
corneal injuries - etiology (1) 1
corneal injuries - metabolism (1) 1
corneal injuries - pathology (1) 1
corneal neovascularization - diagnosis (1) 1
corneal neovascularization - etiology (1) 1
corneal neovascularization - prevention & control (1) 1
corneal wound healing (1) 1
cytokines (1) 1
cytokines - metabolism (1) 1
degeneration (1) 1
delayed-action preparations (1) 1
dendritic cells (1) 1
depletion (1) 1
differentiation (1) 1
disease (1) 1
drug delivery system (1) 1
drug evaluation, preclinical - methods (1) 1
drug implants (1) 1
emergency (1) 1
endothelium (1) 1
endothelium, corneal - cytology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Pathology, The, ISSN 0002-9440, 2017, Volume 187, Issue 6, pp. 1327 - 1342
Alkali burns to the eye constitute a leading cause of worldwide blindness. In recent case series, corneal transplantation revealed unexpected damage to the... 
Pathology | EMERGENCY | TUMOR-NECROSIS-FACTOR | IN-VITRO | CYTOKINES | THERAPY | PROTECTION | BOSTON KERATOPROSTHESIS | ENDOTOXIN | EYE BURNS | PATHOLOGY | GLAUCOMA | Neuroprotective Agents - therapeutic use | Tumor Necrosis Factor-alpha - metabolism | Eye Burns - drug therapy | Retina - metabolism | Apoptosis - drug effects | Burns, Chemical - metabolism | Cornea - immunology | Retina - immunology | Infliximab - therapeutic use | Uveitis, Anterior - pathology | Infliximab - pharmacology | Burns, Chemical - etiology | Corneal Injuries - metabolism | Retinal Ganglion Cells - pathology | Receptors, Tumor Necrosis Factor, Type I - deficiency | Eye Burns - pathology | Corneal Injuries - etiology | Neuroprotective Agents - pharmacology | Uvea - metabolism | Disease Models, Animal | Uveitis, Anterior - prevention & control | Alkalies | Drug Evaluation, Preclinical - methods | Rabbits | Corneal Injuries - pathology | Oxidation-Reduction | Mice, Inbred C57BL | Eye Burns - etiology | Receptors, Tumor Necrosis Factor, Type I - genetics | Uveitis, Anterior - chemically induced | Receptors, Tumor Necrosis Factor, Type II - genetics | Mice, Knockout | Receptors, Tumor Necrosis Factor, Type II - deficiency | Animals | Uveitis, Anterior - metabolism | Burns, Chemical - drug therapy | Burns, Chemical - pathology | Eye Burns - metabolism | Apoptosis - physiology | Corneal Injuries - drug therapy | Retina - pathology | Sodium Hydroxide | Retina - injuries | Retinal Ganglion Cells - drug effects | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Hydrogen-Ion Concentration | Index Medicus | Abridged Index Medicus | Regular
Journal Article
Journal Article
The American Journal of Pathology, ISSN 0002-9440, 07/2018, Volume 188, Issue 7, pp. 1580 - 1596
Eyes that have experienced alkali burn to the surface are excessively susceptible to subsequent severe glaucoma and retinal ganglion cell loss, despite maximal... 
EYE | CELLS | GLUTAMATE RELEASE | ALKALI BURN | DISEASE | CENTRAL-NERVOUS-SYSTEM | TNF-ALPHA | MODEL | PATHOLOGY | NEUROTOXICITY | BRAIN | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Immunology, ISSN 0022-1767, 01/2019, Volume 202, Issue 2, pp. 539 - 549
Reactive microglia and infiltrating peripheral monocytes have been implicated in many neurodegenerative diseases of the retina and CNS. However, their specific... 
CELLS | RECRUITMENT | MARROW-DERIVED MICROGLIA | CONTRIBUTE | ACTIVATION | RISK-FACTORS | BRAIN-INJURY | MOUSE MODEL | INVOLVEMENT | PROLIFERATIVE VITREORETINOPATHY | IMMUNOLOGY
Journal Article
Cornea, ISSN 0277-3740, 02/2018, Volume 37, Issue 2, pp. 248 - 251
Journal Article
Investigative Ophthalmology and Visual Science, ISSN 0146-0404, 01/2017, Volume 58, Issue 1, pp. 96 - 105
PURPOSE. Tumor necrosis factor (TNF)-alpha is upregulated in eyes following corneal alkali injury and contributes to corneal and also retinal damage. Prompt... 
Burn | Corneal wound healing | Tumor necrosis factor alpha | Antibody therapy | Retinal protection | Drug delivery system | Polydimethylsiloxane | burn | SAFETY | polydimethylsiloxane | TRANSPLANTATION | corneal wound healing | PERIPHERAL ULCERATIVE KERATITIS | TOPICAL INFLIXIMAB | tumor necrosis factor alpha | retinal protection | IN-VIVO | OPHTHALMOLOGY | drug delivery system | GLAUCOMA | antibody therapy | Retina - drug effects | Retinal Diseases - prevention & control | Tumor Necrosis Factor-alpha - metabolism | Eye Burns - drug therapy | Retina - metabolism | Burns, Chemical - diagnosis | Follow-Up Studies | Antirheumatic Agents - administration & dosage | Drug Implants | Infliximab - administration & dosage | Corneal Injuries - diagnosis | Cornea - drug effects | Eye Burns - chemically induced | Retinal Diseases - etiology | Female | Cornea - pathology | Eye Burns - diagnosis | Corneal Neovascularization - etiology | Disease Models, Animal | Rabbits | Retinal Diseases - diagnosis | Conjunctiva | Corneal Neovascularization - prevention & control | Cornea - metabolism | Animals | Corneal Neovascularization - diagnosis | Burns, Chemical - drug therapy | Corneal Injuries - drug therapy | Delayed-Action Preparations | Retina - pathology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Index Medicus | Cornea
Journal Article
Cornea, ISSN 0277-3740, 08/2019
PURPOSE:To review clinical aspects and cellular and molecular steps in the development of long-term glaucoma after corneal surgery or acute trauma—especially... 
Index Medicus
Journal Article
Targeted News Service, 05/2017
Newspaper Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.